2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Allan Doctor, MD (he/him/his)

University of Maryland School of Medicine, Maryland

Allan Doctor, MD is Professor of Pediatrics and Bioengineering at the University of Maryland School of Medicine (UMSOM). He is a Pediatric Intensivist and previously led Pediatric Critical Care at Washington University and St Louis Children’s Hospital for 10 years, before transitioning to UMSOM to focus on a rapidly expanding research program and on development of a novel bio-synthetic artificial red cell (ErythroMer). He is a co-Founder and Chief Scientific officer for KaloCyte, which is developing ErythroMer for commercial use. His laboratory studies the role of red blood cell-based signaling in the control of regional blood flow, related pathophysiology arising from acquired red cell injuries, blood substitute design, and on translational transfusion medicine in critical illness. Dr. Doctor has led two translational research networks: NIH/NICHD Collaborative Pediatric Critical Care Research Network and BloodNet, an international group that pursues questions common to Transfusion & Critical Care Medicine. Currently, he directs the University of Maryland Center for Blood Oxygen Transport and Hemostasis (CBOTH), which addresses fundamental, challenging questions related to O2 transport and hemostasis from a systems perspective, and is the Principle Investigator for CONCERT: the US DoD/DARPA funded Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation.

Presentation(s):